glp-1 vs sglt2 diabetes Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study Combining SGLT2 inhibitor and GLP-1

Tirzepatide has dose-dependent adverse effects

The clinical trials that led to FDA approval demonstrated consistent reductions in visceral adipose tissue, measured by imaging

doi: 10.2337/dc20-1983 173

Dzenli kullanmn antrenman younluu ve beslenme dzeniyle uyumlu olmas halinde toparlanma sresi ve kastl enerji kullanm zerinde olumlu etkiler bildirilebilir

Hartl L, Semmler G, Hofer BS, et al

In addition to providing long-term weight loss and possibly remission of T2DM, bariatric surgery is not feasible for large populations, has specific indications, and may result in surgical complications as well as other issues like malabsorption and micronutrient deficiencies